RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-91960 | Pharmaceuticals
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Recombinant Human Follicle-Stimulating Hormone Industry Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET
7.1 GLOBAL RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Uni-Bio Science Group Limited
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Roche
16.3 Abcam
16.4 Sanofi
16.5 Changchun GenSci
16.6 Eli Lilly
16.7 Novo Nordisk
16.8 Merck (Schweiz) AG
16.9 NCPC
16.10 Merck Serono Europe Ltd
16.11 Amgen
16.12 Ortho Biotech
16.13 3SBio Inc
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :Injection
Freeze-dried powder
Market by Application :
Hospital use
Clinic use
Household
Companies
Uni-Bio Science Group Limited
Roche
Abcam
Sanofi
Changchun GenSci
Eli Lilly
Novo Nordisk
Merck (Schweiz) AG
NCPC
Merck Serono Europe Ltd
Amgen
Ortho Biotech
3SBio Inc
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.